Australia's largest stock trading and investment forum Australia's #1 stock forum

Why is Pfizer Vacine not available?, page-9

First 9 Last

Share
Profile

Follow
moorookamick

23,954 Posts.

770

30/03/21

21:20

Post #: 52155105
Share

Originally posted by moorookamick: ↑

Canada has paused its Astra Zeneca under 55s roll out because of the risk of blood clots.
This is the second time since mid March that blood clots have been associated with A.Z.

Unlike us the bulk of Canada's supply which is Pfizer & Modena with a small fraction of A.Z,
Australia has the opposite

Lancet remarks that AZ is good for 3rd world countries because:
-its cheap
-its easily storable and distributable because it doesn't need freezing

How 3rd country is Aus?
Perhaps our Government has 3rd world attitudes ..eh?

When I inquired today from Queensland Health why Pfizer was not available for the over 70s (class 1b)
I was told that AZ was the only available brand...take it or leave it.

The lady added that AZ was made in Aus as if that compensated for qualities that did not measure up to Pfizer or Modena.

Over 70s, particularly those with Arterial Fibrillation (AF) are more prone to blood clotting than others and
the over 70s have the highest incidence of AF by far.

The question is the over 70s being sold a pup to save the Morrison Government money because
the Pfizer shot costs 5 times that of the AZ ?
IMO, yes !

Expand

PS: More recent AZ bottles have a blood clotting warning.

here is the Canada article link of yesterday:

https://apnews.com/article/canada-panel-astrazeneca-vaccine-pause-under-55-06dde56d2db78d72c5bb9bcb97be4d5a

Last edited by moorookamick: 30/03/21
1 Upvote

Reply

Top Stories

AII

Inside the depths of Panasqueira: A legacy carved in rock

Monday's HotCopper trends: Northern Star forecast, AML3D Navy handshake | July 7

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

Trump chides Powell as Goldman call for calm. The RBA must be nervous

ASX Market Close: Trump tariffs paused til August; CBA falls below $300B